Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Treatment of optic neuritis with erythropoietin (TONE): a randomised, double-blind, placebo-controlled trial-study protocol.
Novel cerebrospinal fluid and serum autoantibody targets for Clinically Isolated Syndrome.
A method for estimating intracellular sodium concentration and extracellular volume fraction in brain in vivo using sodium magnetic resonance imaging.
Level of attitude toward complementary and alternative medicine among Iranian patients with multiple sclerosis.
Physical Disability, Anxiety and Depression in People with MS: An Internet-Based Survey via the UK MS Register.
Two decades of subcutaneous glatiramer acetate injection: current role of the standard dose, and new high-dose low-frequency glatiramer acetate in relapsing-remitting multiple sclerosis treatment.
MRI pattern in asymptomatic natalizumab-associated PML.
Differentiating white matter lesions in multiple sclerosis and migraine using monoexponential and biexponential diffusion measurements.
Children and adolescents adjustment to parental multiple sclerosis: a systematic review.
Worsening essential tremor following deep brain stimulation: disease progression versus tolerance.
Differential effects of fingolimod (FTY720) on immune cells in the CSF and blood of patients with MS.
Matrine ameliorates experimental autoimmune encephalomyelitis by modulating chemokines and their receptors.
Vitamin D deficiency in multiple sclerosis: Should testing and treatment be based on racial background?
The redox state of the alarmin HMGB1 is a pivotal factor in neuroinflammatory and microglial priming: a role for the NLRP3 inflammasome.
[Concepts and epidemiology of combined central and peripheral demyelination].
Cognitive assessment in MS.
Health-related quality of life in relapsing remitting multiple sclerosis patients during treatment with glatiramer acetate: a prospective, observational, international, multi-centre study.
Elevation of Tumor Necrosis Factor Alpha in Dorsal Root Ganglia and Spinal Cord is Associated with Neuroimmune Modulation of Pain in an Animal Model of Multiple Sclerosis.
Reduced habituation of the retinal ganglion cell response to sustained pattern stimulation in multiple sclerosis patients.
The fine balance of chemokines during disease: trafficking, inflammation, and homeostasis.
The role of aquaporin-4 antibodies in Chinese patients with neuromyelitis optica.
Benign course of tumour-like multiple sclerosis. Report of five cases and literature review.
Oligodendroglia and neurotrophic factors in neurodegeneration.
The best clinical paper on multiple sclerosis in 2012: Commentary.
DTI Measurements in Multiple Sclerosis: Evaluation of Brain Damage and Clinical Implications.
Pages
« first
‹ previous
…
449
450
451
452
453
454
455
456
457
…
next ›
last »